Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5188550
Max Phase: Preclinical
Molecular Formula: C48H55Cl2N7O7S
Molecular Weight: 944.98
Associated Items:
ID: ALA5188550
Max Phase: Preclinical
Molecular Formula: C48H55Cl2N7O7S
Molecular Weight: 944.98
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCOCCOc2ccc(-c3cn4c(n3)CCC4)cc2CNC(=O)Cc2ccc(Cl)c(Cl)c2)C(C)(C)C)cc1
Standard InChI: InChI=1S/C48H55Cl2N7O7S/c1-29-44(65-28-53-29)32-10-7-30(8-11-32)24-52-46(61)39-23-35(58)26-57(39)47(62)45(48(2,3)4)55-42(59)15-17-63-18-19-64-40-14-12-33(38-27-56-16-5-6-41(56)54-38)22-34(40)25-51-43(60)21-31-9-13-36(49)37(50)20-31/h7-14,20,22,27-28,35,39,45,58H,5-6,15-19,21,23-26H2,1-4H3,(H,51,60)(H,52,61)(H,55,59)/t35-,39+,45-/m1/s1
Standard InChI Key: HXWVYVXJBYTQQT-TZEXNLEWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 944.98 | Molecular Weight (Monoisotopic): 943.3261 | AlogP: 6.69 | #Rotatable Bonds: 18 |
Polar Surface Area: 177.01 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 4 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.25 | CX Basic pKa: 5.92 | CX LogP: 4.85 | CX LogD: 4.84 |
Aromatic Rings: 5 | Heavy Atoms: 65 | QED Weighted: 0.07 | Np Likeness Score: -0.99 |
1. Dölle A, Adhikari B, Krämer A, Weckesser J, Berner N, Berger LM, Diebold M, Szewczyk MM, Barsyte-Lovejoy D, Arrowsmith CH, Gebel J, Löhr F, Dötsch V, Eilers M, Heinzlmeir S, Kuster B, Sotriffer C, Wolf E, Knapp S.. (2021) Design, Synthesis, and Evaluation of WD-Repeat-Containing Protein 5 (WDR5) Degraders., 64 (15.0): [PMID:33980013] [10.1021/acs.jmedchem.1c00146] |
Source(1):